The Use of ARA290 for the Treatment of Diabetic Macular Oedema

NCT06626971 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

9

Enrollment

OTHER

Sponsor class

Stopped Expiry of study drug - no replacement available.

Conditions

Diabetic Macular Oedema

Interventions

DRUG: ARA290

Sponsor

Belfast Health and Social Care Trust

Collaborators

[object Object]